Hualan Biological Engineering
002007.SZ
#3436
Rank
HK$31.10 B
Marketcap
HK$17.02
Share price
0.32%
Change (1 day)
-3.66%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

EPS for Hualan Biological Engineering (002007.SZ)

EPS in 2025 (TTM): HK$0.72

According to Hualan Biological Engineering's latest financial reports the company's current EPS (TTM) is HK$0.71. In 2024 the company made an earnings per share (EPS) of HK$0.64 a decrease over its 2023 EPS that were of HK$0.89.

EPS history for Hualan Biological Engineering from 2001 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$0.7212.97%
2024HK$0.64-28.94%
2023HK$0.8934.37%
2022HK$0.67-23.62%
2021HK$0.87-17.72%
2020HK$1.0634.52%
2019HK$0.7910.7%
2018HK$0.7131.33%
2017HK$0.5412.27%
2016HK$0.4823.63%
2015HK$0.394.49%
2014HK$0.3710%
2013HK$0.3463.02%
2012HK$0.21-18.48%
2011HK$0.26-36.3%
2010HK$0.403.95%
2009HK$0.39217.39%
2008HK$0.1265.37%
2007HK$0.0734963.5%
2006HK$0.0449553.73%
2005HK$0.0292430.17%
2004HK$0.02246-21.73%
2003HK$0.0287023.16%
2002HK$0.0233086.73%
2001HK$0.01248